The study identifies specific subdomains and tyrosine residues of the Mpl cytoplasmic domain critical for TPO-induced proliferation and signaling pathways, including a novel indirect pathway to STAT5 activation.
No takes yet. Share an insight, caveat, or question.
These Mpl subdomain findings warrant no clinical practice change; leaves open targeted receptor engineering in thrombopoiesis.
Drachman et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: